Brook StarRay Wireless Controller Now Available — Native PS5 Support Meets Xbox-Style Control 
OpenWorld (NASDAQ: OPNW) Signs Definitive Merger Agreement to Acquire Blocksight 
Scalare Launches EquityRoom, Adding a Subscription Revenue Stream to Its Founder Ecosystem 
Megaannum Capital and Zhongke Xianxing Venture Capital Enter into Strategic Partnership Siren Biotechnology Launches to Pioneer Universal AAV Immuno-Gene Therapy™ for Cancer
Universal AAV Immuno-Gene Therapy for Cancer A novel approach to fight cancer that combines the…
Opthea to Participate in EF Hutton Hosted Discussion on OPT-302 and the Wet AMD Market
MELBOURNE, Australia, May 17, 2023 (GLOBE NEWSWIRE) — Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage…
Alvotech to Participate in Morgan Stanley Annual Sustainable Finance Summit
REYKJAVIK, Iceland, May 17, 2023 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech company…
Alvotech to Participate in Morgan Stanley Annual Sustainable Finance Summit
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar…
VIVUS’ QSIVA in Combination with a Digital Lifestyle Intervention Leads to Significant Weight Loss and Decreased Cardiovascular Risk in Patients with Obesity
— Poster presented at the 30th European Congress on Obesity (ECO 2023) shows addition of…
InterDigital and Philips to Showcase Video-Based Immersive Codecs and Content Creation Pipelines Enabling XR Opportunities at AWE USA 2023
WILMINGTON, Del., May 17, 2023 (GLOBE NEWSWIRE) — The roll-out of high speed and high…
Agilent Wins SEAL Award for Innovative Products that Help Customers Achieve Their Sustainability Goals
SANTA CLARA, Calif.–(BUSINESS WIRE)–Agilent Technologies Inc. (NYSE: A) today received a SEAL Business Sustainability Award…
FendX Expands Its Nanotechnology Platform by Signing an Exclusive Worldwide License for Spray Coating Formulation
Oakville, Ontario–(Newsfile Corp. – May 17, 2023) – FendX Technologies Inc. (CSE: FNDX) (the “Company”…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Beyond Meat, Inc. (BYND) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
Gartner Says Sales Leaders Who Position Technology As a Teammate Rather Than a Tool will Unlock Seller Productivity and High-Quality Deals
Experts Explore the Power of AI in Augmenting Sellers’ Abilities During Gartner CSO & Sales…
BigOrange Marketing Discusses Best Practices for ChatGPT at National IT Conference
StoryBrand Marketing professional chosen to speak at IT Nation three years in a row CINCINNATI–(BUSINESS…
neXat expands further East with KT SAT partnership
17 May 2023 – neXat has entered a partnership with KT SAT to offer the…
Coave Therapeutics to Participate in Upcoming Conferences
Paris, France, May 17, 2023 – Coave Therapeutics (‘Coave’), a clinical-stage biotechnology company focused on…
Coave Therapeutics to Participate in Upcoming Conferences
Paris, France, May 17, 2023 – Coave Therapeutics (‘Coave’), a clinical-stage biotechnology company focused on…
Sania Therapeutics launches to advance novel medicines for neural circuit dysfunction
Sania Therapeutics launches to advance novel medicines for neural circuit dysfunction Sania emerges from stealth…
Sania Therapeutics launches to advance novel medicines for neural circuit dysfunction
Sania Therapeutics launches to advance novel medicines for neural circuit dysfunction Sania emerges from stealth…
BioSenic reacquires global IP rights and provides update on JTA-004 development
INSIDE INFORMATION BioSenic plans to further develop its program on an active injectable viscosupplement JTA,…
BioSenic reacquires global IP rights and provides update on JTA-004 development
INSIDE INFORMATION BioSenic plans to further develop its program on an active injectable viscosupplement JTA,…
Ipsen to present new Bylvay® (odevixibat) data at annual ESPGHAN congress, showcasing commitment to furthering treatment for rare cholestatic liver diseases
Six abstracts to be presented demonstrating efficacy and tolerability of investigational Bylvay in select cholestatic…
Ipsen to present new Bylvay® (odevixibat) data at annual ESPGHAN congress, showcasing commitment to furthering treatment for rare cholestatic liver diseases
Six abstracts to be presented demonstrating efficacy and tolerability of investigational Bylvay in select cholestatic…